Cargando…

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222) vaccine in the United Kingdom was analyzed to dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Shuo, Phillips, Daniel J., White, Thomas, Sayal, Homesh, Aley, Parvinder K., Bibi, Sagida, Dold, Christina, Fuskova, Michelle, Gilbert, Sarah C., Hirsch, Ian, Humphries, Holly E., Jepson, Brett, Kelly, Elizabeth J., Plested, Emma, Shoemaker, Kathryn, Thomas, Kelly M., Vekemans, Johan, Villafana, Tonya L., Lambe, Teresa, Pollard, Andrew J., Voysey, Merryn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604724/ https://www.ncbi.nlm.nih.gov/pubmed/34588689 http://dx.doi.org/10.1038/s41591-021-01540-1

Ejemplares similares

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
por: Marchevsky, Natalie Gabrielle, et al.
Publicado: (2022)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
por: Clemens, Sue Ann Costa, et al.
Publicado: (2021)

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials
por: Voysey, Merryn, et al.
Publicado: (2023)

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
por: Flaxman, Amy, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
por: Folegatti, Pedro M, et al.
Publicado: (2020)

Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7C
por: Tiley, Karen S, et al.
Publicado: (2022)

Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials
por: Voysey, Merryn, et al.
Publicado: (2016)

Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates
por: Voysey, Merryn, et al.
Publicado: (2017)

Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias
por: Voysey, Merryn, et al.
Publicado: (2018)

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
por: Barrett, Jordan R., et al.
Publicado: (2021)

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
por: Ramasamy, Maheshi N, et al.
Publicado: (2020)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
por: Emary, Katherine R W, et al.
Publicado: (2021)

An Appraisal of the Clinical Features of Pediatric Enteric Fever: Systematic Review and Meta-analysis of the Age-Stratified Disease Occurrence
por: Britto, Carl, et al.
Publicado: (2017)

The Design and Analysis of Seroefficacy Studies for Typhoid Conjugate Vaccines
por: Liu, Xinxue, et al.
Publicado: (2019)

Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences
por: Voysey, Merryn, et al.
Publicado: (2018)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
por: Madhi, Shabir A, et al.
Publicado: (2021)

AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T(H)1 response with a diverse TCR repertoire
por: Swanson, Phillip A., et al.
Publicado: (2021)

Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers
por: McCullagh, David, et al.
Publicado: (2015)

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
por: Costa Clemens, Sue Ann, et al.
Publicado: (2022)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
por: Li, Grace, et al.
Publicado: (2022)

Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine
por: Aguas, Ricardo, et al.
Publicado: (2021)

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination
por: Hillson, Kushalinii, et al.
Publicado: (2021)

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
por: Voysey, Merryn, et al.
Publicado: (2021)

Mixed effects approach to the analysis of the stepped wedge cluster randomised trial - accounting for the confounding effect of time
por: Nickless, Alecia, et al.
Publicado: (2015)

Mixed effects approach to the analysis of the stepped wedge cluster randomised trial—Investigating the confounding effect of time through simulation
por: Nickless, Alecia, et al.
Publicado: (2018)

Diagnostic accuracy of Fever-PAIN and Centor criteria for bacterial throat infection in adults with sore throat: a secondary analysis of a randomised controlled trial
por: Seeley, Anna, et al.
Publicado: (2021)

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
por: Mentzer, Alexander J., et al.
Publicado: (2022)

Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults
por: Lazarus, Rajeka, et al.
Publicado: (2016)

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
por: Carr, Jeremy, et al.
Publicado: (2020)

Applying the intention-to-treat principle in practice: Guidance on handling randomisation errors
por: Yelland, Lisa N, et al.
Publicado: (2015)

Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant Immunization: Follow-Up from a Randomized Controlled Trial
por: Trück, Johannes, et al.
Publicado: (2014)

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
por: Madhi, Shabir A., et al.
Publicado: (2021)

Giant viable hydatid cyst of the lung: a case report
por: Ghallab, Nagi Homesh, et al.
Publicado: (2008)

Non-specific immunological effects of selected routine childhood immunisations: systematic review
por: Kandasamy, Rama, et al.
Publicado: (2016)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
por: Voysey, Merryn, et al.
Publicado: (2021)

Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal
por: Shrestha, Sonu, et al.
Publicado: (2021)

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021
por: Ratcliffe, Helen, et al.
Publicado: (2023)

Under-detection of blood culture-positive enteric fever cases: The impact of missing data and methods for adjusting incidence estimates
por: Voysey, Merryn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k19q1u3h1lk1pi4lj7ci4bejhm